argenx (ARGX) Launches Proposed $500M Global Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
argenx announces launch of proposed global offering
March 22, 2022 4:15 PM EDTRegulated information Inside information
March 22, 2022
Breda, the Netherlands argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced today that it has commenced a global offering of $500 million (approximately 453 million) of ordinary shares, which may be represented by American Depository Shares (ADSs). The global offering will be comprised of an offering of ordinary shares represented by ADSs in the United States and certain other countries... More
